Buprenorphine for Opioid and Cocaine Dependence

  • Marc I. Rosen
  • Thomas R. Kosten
Part of the Drug and Alcohol Abuse Reviews book series (DAAR, volume 4)

Abstract

Pharmacological treatment for opioid dependence currently employs one of two general approaches: maintenance with an opioid agonist such as methadone,1 or detoxification and induction onto the opioid antagonist naltrexone. Buprenorphine is a mixed opioid agonist/antagonist that may help addicts for whom conventional detoxification or methadone-maintenance treatments are not effective.

Keywords

Placebo Depression Cage Morphine Cocaine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    J.R. Cooper, F. Altman, B.S. Brown, and D. Czechowicz (1983) Research on the Treatment of Narcotic Addiction. National Institute of Mental Health, Rockville, MD.Google Scholar
  2. 2.
    P. Cushman and V.P. Dole (1973) Detoxification of methadone maintenance patients. JAMA 226, 747–751.PubMedCrossRefGoogle Scholar
  3. 3.
    E.C. Senay, W.Doms, F. Goldberg, and W. Thornton (1977) Withdrawal from methadone maintenance. Arch. Gen. Psychiatry 34, 361–367.Google Scholar
  4. 4.
    G.A. Gilman, L.S. Goodman, T.W. Rall, and F. Murad (eds.) (1985) The Pharmacological Basis of Therapeutics. 7th ed. Macmillan, New York.Google Scholar
  5. 5.
    R.W. Houde (1979) Analgesic effectiveness of the narcotic agonistantagonists. Br. J. Clin. Pharmacol. 7, 297S–308S.PubMedCrossRefGoogle Scholar
  6. 6.
    S.L. Walsh, K.L. Preston, M.L. Stitzer, G. E. Bigelow, and I.A. Liebson (1991) The acute effects of high dose buprenorphine in non-dependent humans. Proceedings of the Committee on Problems of Drug Dependence 1991. L.S. Harris, ed. National Institute on Drug Abuse, Rockville, MD, in press.Google Scholar
  7. 7.
    T.J. Gal (1989) Naloxone reversal of buprenorphine—induced respiratory depression. Clin. Pharmacol. Ther. 45, 66–71.PubMedCrossRefGoogle Scholar
  8. 8.
    K.L. Preston, G.E. Bigelow, and I.A. Liebson (1988) Buprenorphine and naloxone alone and in combination in opioid-dependent humans. Psychopharmacology 44, 484–490.CrossRefGoogle Scholar
  9. 9.
    D.R. Jasinski, P.J. Fudala, and R.E. Johnson (1989) Sublingual versus subcutaneous buprenorphine in opiate abusers. Clin. Pharm. Ther. 45, 513–519.CrossRefGoogle Scholar
  10. 10.
    J.W. Louis (1985) Buprenorphine. Drug Alcohol Depend. 14, 363–372.CrossRefGoogle Scholar
  11. 11.
    M.S. Gold, D.E. Redmond, and H.D. Kleber (1978) Clonidine in opiate withdrawal. Lancet 1, 929–930.PubMedCrossRefGoogle Scholar
  12. 12.
    E. Vining, T.R. Kosten, and H.D. Kleber (1988) Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers. Br. J. Addict. 83, 567–575.PubMedCrossRefGoogle Scholar
  13. 13.
    D.R. Jasinski, J.S. Pevnick, and J.D. Griffith (1978) Human pharmacology and abuse potential of the analgesic buprenorphine. Arch. Gen. Psychiatry 35, 501–516.PubMedCrossRefGoogle Scholar
  14. 14.
    J.E. Dum, J. Blasig, and A. Herz (1981) Buprenorphine: physical dependence and liability. Eur. J. Pharmacol. 70, 293–300.PubMedCrossRefGoogle Scholar
  15. 15.
    W.K. Bickel, M.L. Stitzer, G.E. Bigelow, I.A. Liebson, P.R. Jasinski, and R.E. Johnson (1988) A clinical trial of buprenorphine: Comparison with methadone in the detoxification of heroin addicts. Clin. Pharmacol. Ther. 43, 72–78.PubMedCrossRefGoogle Scholar
  16. 16.
    T.R. Kosten and H.D. Kleber (1988) Buprenorphine detoxification from opioid dependence. Life Sci. 42,635–641.PubMedCrossRefGoogle Scholar
  17. 17.
    T.R. Kosten, C. Morgan, and H.D. Kleber (1991) Treatment of heroin addicts using buprenorphine. Am. J. Drug Alcohol Abuse 17(2), 119–228.PubMedCrossRefGoogle Scholar
  18. 18.
    R. Kosten New approaches for rapid detoxification and induction onto naltrexone. Adv. AIohol. Subst. Abuse,in press.Google Scholar
  19. 19.
    D.S. Charney, D.E. Redmond, M.P. Galloway, H.D. Kleber, G.R. Heninger, M. Murberg, and R.H. Roth (1984) Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: evidence for moradrenergic hypoactivity. Life Sci. 35, 1263–1272.PubMedCrossRefGoogle Scholar
  20. 20.
    W.K. Bickel, M.L. Stitzer, G.E. Bigelow, I.A. Liebson, D.R. Jasinksi, and R. E. Johnson (1988) Buprenorphine dose related blockade of opioid challenge effects in opioid dependent humans. J. Pharm. Exp. Ther. 247,47–53.Google Scholar
  21. 21.
    E.A. Wallace, M.I. Rosen, H.R. Pearsall, S.W. Woods, L.H. Price, C.J. McDougle, and T.R. Kosten (1992) Buprenorphine: duration of blockade of effects of intramuscular opioids. Committee on the Problems of Drug Dependence 1992, submitted abstract.Google Scholar
  22. 22.
    N.K. Mello, J.H. Mendelson, and U.C. Kuehnle (1982) Buprenorphine effects on human heroin self-administration: an operant analysis. J. Pharmacol. Exp. Ther. 223(1), 30–39.PubMedGoogle Scholar
  23. 23.
    J.H. Mendelson (1983) Comparison of buprenorphine and methadone effects on opiate self-administration in primates. J. Pharmacol. Exp. Ther. 225(2), 378–386.PubMedGoogle Scholar
  24. 24.
    R.W. Foltin and M.W. Fischmann (1990) The Cardiovascular and Subjective Affects of Intravenous Cocaine and Morphine Combinations (“Speedballs”) in Humans. American College of Neuropsychopharmacology.Google Scholar
  25. 25.
    I.R. Kosten, B.J. Rounsaville, and H.D. Kleber (1988) Antecedents and consequences of cocaine abuse among opioid addicts: a 2.5 year follow up. J. Nerv. Men. Disease 176, 176–181.CrossRefGoogle Scholar
  26. 26.
    C.E. Johanson and M.W. Fischman (1989) The pharmacology of cocaine related to its abuse. Pharmacal. Rev. 41(1), 3–52.Google Scholar
  27. 27.
    A. Kosten, D.W. Marby, and E.J. Nestler (1991) Chronic buprenorphine attenuates cocaine conditioned placed preference, in Proceedings of the Committee on Problems of Drug Dependence 1991. L. S. Harris, ed. National Institute on Drug Abuse, Rockville, MD, in press.Google Scholar
  28. 28.
    N.K. Mello, J.H. Mendelson, M.B. Bree, and S.E. Lukas (1989) Buprenorphine suppresses cocaine self-administration by Rhesus monkeys. Science 245, 859–862.PubMedCrossRefGoogle Scholar
  29. 29.
    M.I. Rosen, H.R. Pearsall, C.J. McDougle, L.H. Price, S.W. Woods, and T.R. Kasten (1992) Effects of acute buprenorphine on responses to intranasal cocaine. Proceedings ofthe Committee on the Problems of Drug Dependence 1992, submitted abstractGoogle Scholar
  30. 30.
    S.K. Teoh, P. Sintavanarong, J. Kuehnle, J.H. Mendelson, E. Hallring, E. Rhoades, and N.K. Mello (1991) Buprenorphine effects on morphine and cocaine hallenges in heroin and cocaine dependent men, in Proceedings of the Committee on Problems of Drug Dependence 1991. L. S. Harris, ed. National Institute on Drug Abuse, Rockville, MD, in pressGoogle Scholar
  31. 31.
    T.R. Kasten, H.D. Kleber, and C. Morgan (1989) Treatment of cocaine abuse with buprenorphine. Biol. Psychiatry 26, 637–639.CrossRefGoogle Scholar
  32. 32.
    R.E. Johnson, P.J. Fudala, and J.H. Jaffey (1990) Outpatient comparison of buprenorphine and methadone maintenance. I. Effects on opiate use and self-reported adverse effects and withdrawal symptomatology, in Proceedings of the Committee on Problems of Drug Dependence 1991. L. S. Harris, ed. National Institute on Drug Abuse, Rockville, MD, pp. 585,586.Google Scholar
  33. 33.
    P.J. Fudala, R.E. Johnson, and J.H. Jaffey (1990) Outpatient comparison of buprenorphine and methadone maintenance. II. Effects on cocaine usage, retention time and study and missed clinic visits, in Proceedings of the Committee on Problems of Drug Dependence 1991. L. S. Harris, ed. National Institute on Drug Abuse, Rockville, MD, pp. 587,588.Google Scholar
  34. 34.
    T.R. Kosten, R.S. Schottenfeld, C.H. Morgan, J. Falcioni, and D. Ziedonis (1991) Buprenorphine vs methadone for opiaid and cocaine dependence, in Proceedings of the Committee on Problems of Drug Dependence 1991. L. S. Harris, ed. National Institute on Drug Abuse, Rockville, MD, in press.Google Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • Marc I. Rosen
  • Thomas R. Kosten

There are no affiliations available

Personalised recommendations